日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells

工程化双特异性AChR CAAR T细胞用于选择性消除重症肌无力B细胞

von Wardenburg, Niels; Spagni, Gregorio; Reincke, S Momsen; Wernick, Stephanie; Kornau, Hans-Christian; Zinnow, Viktoria; Keles, Amelya; Li, Lucie Y; Homeyer, Marie A; Blumenau, Sonja; Stecklum, Maria; Schmitz, Dietmar; Pelz, Andreas; Damato, Valentina; Sanderson, Nicholas; Derfuß, Tobias; Pham, Minh C; O'Connor, Kevin C; Meisel, Andreas; Prüss, Harald

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).

早期短期 PXT3003 联合疗法可延缓 Charcot-Marie-Tooth 病 1A (CMT1A) 转基因大鼠模型的疾病发作

Prukop Thomas, Stenzel Jan, Wernick Stephanie, Kungl Theresa, Mroczek Magdalena, Adam Julia, Ewers David, Nabirotchkin Serguei, Nave Klaus-Armin, Hajj Rodolphe, Cohen Daniel, Sereda Michael W